Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular PreventionUdo Hoffmann, Robert T. OʼDonnell, Michael T. Lu et al.|JAMA Network Open|2021Cited by 82
PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)Roy M. Gulick, Kenneth H. Mayer, Leslie Cottle et al.|The Journal of Infectious Diseases|2016Cited by 47
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in WomenRoy M. Gulick, Kenneth H. Mayer, Timothy Wilkin et al.|Annals of Internal Medicine|2017Cited by 31
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S. Venuto, Jeffrey L. Lennox, Katie R. Mollan et al.|Journal of Antimicrobial Chemotherapy|2014Cited by 20
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202Cindy J. Bednasz, Mitchell Goldman, Charles S. Venuto et al.|Antimicrobial Agents and Chemotherapy|2019Cited by 16